|
1
|
Wang X and Dai J: Concise review: isoforms
of OCT4 contribute to the confusing diversity in stem cell biology.
Stem Cells. 28:885–893. 2010.PubMed/NCBI
|
|
2
|
Jerabek S, Merino F, Scholer HR and
Cojocaru V: OCT4: dynamic DNA binding pioneers stem cell
pluripotency. Biochim Biophys Acta. 1839.138–154. 2014.
|
|
3
|
Jung M, Peterson H, Chavez L, et al: A
data integration approach to mapping OCT4 gene regulatory networks
operative in embryonic stem cells and embryonal carcinoma cells.
PLoS One. 5:e107092010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Young RA: Control of the embryonic stem
cell state. Cell. 144:940–954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park IH, Zhao R, West JA, et al:
Reprogramming of human somatic cells to pluripotency with defined
factors. Nature. 451:141–146. 2008. View Article : Google Scholar
|
|
6
|
Takahashi K, Tanabe K, Ohnuki M, et al:
Induction of pluripotent stem cells from adult human fibroblasts by
defined factors. Cell. 131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu J, Vodyanik MA, Smuga-Otto K, et al:
Induced pluripotent stem cell lines derived from human somatic
cells. Science. 318:1917–1920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cauffman G, Liebaers I, Van Steirteghem A
and Van de Velde H: POU5F1 isoforms show different expression
patterns in human embryonic stem cells and preimplantation embryos.
Stem Cells. 24:2685–2691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pain D, Chirn GW, Strassel C and Kemp DM:
Multiple retropseudogenes from pluripotent cell-specific gene
expression indicates a potential signature for novel gene
identification. J Biol Chem. 280:6265–6268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suo G, Han J, Wang X, Zhang J, Zhao Y and
Dai J: Oct4 pseudogenes are transcribed in cancers. Biochem Biophys
Res Commun. 337:1047–1051. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang L, Guo ZY, Zhang R, et al: Pseudogene
OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4
expression by competing for miR-145 in hepatocellular carcinoma.
Carcinogenesis. 34:1773–1781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayashi H, Arao T, Togashi Y, et al: The
OCT4 pseudogene POU5F1B is amplified and promotes an aggressive
phenotype in gastric cancer. Oncogene. Dec 23–2013.(Epub ahead of
print). PubMed/NCBI
|
|
13
|
Panagopoulos I, Moller E, Collin A and
Mertens F: The POU5F1P1 pseudogene encodes a putative protein
similar to POU5F1 isoform 1. Oncol Rep. 20:1029–1033.
2008.PubMed/NCBI
|
|
14
|
Breyer JP, Dorset DC, Clark TA, et al: An
expressed retrogene of the master embryonic stem cell gene POU5F1
is associated with prostate cancer susceptibility. Am J Hum Genet.
94:395–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu J, Ma L, Xu J, et al: Spheroid
body-forming cells in the human gastric cancer cell line MKN-45
possess cancer stem cell properties. Int J Oncol. 42:453–459.
2013.
|
|
16
|
Liedtke S, Stephan M and Kogler G: Oct4
expression revisited: potential pitfalls for data misinterpretation
in stem cell research. Biol Chem. 389:845–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cantz T, Key G, Bleidissel M, et al:
Absence of OCT4 expression in somatic tumor cell lines. Stem Cells.
26:692–697. 2008. View Article : Google Scholar
|
|
18
|
Lengner CJ, Welstead GG and Jaenisch R:
The pluripotency regulator Oct4: a role in somatic stem cells? Cell
Cycle. 7:725–728. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mueller T, Luetzkendorf J, Nerger K,
Schmoll HJ and Mueller LP: Analysis of OCT4 expression in an
extended panel of human tumor cell lines from multiple entities and
in human mesenchymal stem cells. Cell Mol Life Sci. 66:495–503.
2009. View Article : Google Scholar
|
|
20
|
Jez M, Ambady S, Kashpur O, et al:
Expression and differentiation between OCT4A and its pseudogenes in
human ESCs and differentiated adult somatic cells. PLoS One.
9:e895462014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei F, Scholer HR and Atchison ML:
Sumoylation of Oct4 enhances its stability, DNA binding, and
transactivation. J Biol Chem. 282:21551–21560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu H, Wang W, Li C, et al: WWP2 promotes
degradation of transcription factor OCT4 in human embryonic stem
cells. Cell Res. 19:561–573. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saxe JP, Tomilin A, Scholer HR, Plath K
and Huang J: Post-translational regulation of Oct4 transcriptional
activity. PLoS One. 4:e44672009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brumbaugh J, Hou Z, Russell JD, et al:
Phosphorylation regulates human OCT4. Proc Natl Acad Sci USA.
109:7162–7168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin Y, Yang Y, Li W, et al: Reciprocal
regulation of Akt and Oct4 promotes the self-renewal and survival
of embryonal carcinoma cells. Mol Cell. 48:627–640. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Campbell PA and Rudnicki MA: Oct4
interaction with Hmgb2 regulates Akt signaling and pluripotency.
Stem Cells. 31:1107–1120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen B, Xue Z, Yang G, et al: Akt-signal
integration is involved in the differentiation of embryonal
carcinoma cells. PLoS One. 8:e648772013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Padhye SS, Guin S, Yao HP, Zhou YQ, Zhang
R and Wang MH: Sustained expression of the RON receptor tyrosine
kinase by pancreatic cancer stem cells as a potential targeting
moiety for antibody-directed chemotherapeutics. Mol Pharm.
8:2310–2319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang K, Li Y, Jiang YZ, et al: An
endogenous aryl hydrocarbon receptor ligand inhibits proliferation
and migration of human ovarian cancer cells. Cancer Lett.
340:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ
and Andrews PW: OCT4 spliced variants are differentially expressed
in human pluripotent and nonpluripotent cells. Stem Cells.
26:3068–3074. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao GJ, Xu LX, Chu ES, et al:
Establishment of an orthotopic transplantation tumor model of
hepatocellular carcinoma in mice. World J Gastroenterol.
18:7087–7092. 2012. View Article : Google Scholar
|
|
32
|
Ledur PF, Villodre ES, Paulus R, Cruz LA,
Flores DG and Lenz G: Extracellular ATP reduces tumor sphere growth
and cancer stem cell population in glioblastoma cells. Purinergic
Signal. 8:39–48. 2012. View Article : Google Scholar :
|
|
33
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
34
|
Wu R, Zhang L, Hoagland MS and Swanson HI:
Lack of the aryl hydrocarbon receptor leads to impaired activation
of AKT/protein kinase B and enhanced sensitivity to apoptosis
induced via the intrinsic pathway. J Pharmacol Exp Ther.
320:448–457. 2007. View Article : Google Scholar
|
|
35
|
Wang C, Xu CX, Bu Y, Bottum KM and
Tischkau SA: Beta-naphthoflavone (DB06732) mediates estrogen
receptor-positive breast cancer cell cycle arrest through
AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.
Carcinogenesis. 35:703–713. 2014. View Article : Google Scholar :
|
|
36
|
Molina JR, Hayashi Y, Stephens C and
Georgescu MM: Invasive glioblastoma cells acquire stemness and
increased Akt activation. Neoplasia. 12:453–463. 2010.PubMed/NCBI
|
|
37
|
Haas-Kogan D, Shalev N, Wong M, Mills G,
Yount G and Stokoe D: Protein kinase B (PKB/Akt) activity is
elevated in glioblastoma cells due to mutation of the tumor
suppressor PTEN/MMAC. Curr Biol. 8:1195–1198. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J and Zhou BP: Activation of β-catenin
and Akt pathways by Twist are critical for the maintenance of EMT
associated cancer stem cell-like characters. BMC Cancer. 11:492011.
View Article : Google Scholar
|
|
39
|
Dubrovska A, Kim S, Salamone RJ, et al:
The role of PTEN/Akt/PI3K signaling in the maintenance and
viability of prostate cancer stem-like cell populations. Proc Natl
Acad Sci USA. 106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang XQ, Ongkeko WM, Chen L, et al:
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver
cancer cells through a potential Oct4-AKT-ATP-binding cassette G2
pathway. Hepatology. 52:528–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Korkaya H, Paulson A, Charafe-Jauffret E,
et al: Regulation of mammary stem/progenitor cells by
PTEN/Akt/beta-catenin signaling. PLoS Biol. 7:e10001212009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bleau AM, Hambardzumyan D, Ozawa T, et al:
PTEN/PI3K/Akt pathway regulates the side population phenotype and
ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell.
4:226–235. 2009. View Article : Google Scholar : PubMed/NCBI
|
